Transphorm, Inc. (TGAN)
Jun 20, 2024 - TGAN was delisted (reason: acquired by Renesas)
5.10
+0.34 (7.14%)
Last trade price

Transphorm Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Year Ending
TTM Mar 31, 2023Mar 31, 2022Dec 31, 2020Dec 31, 2019Dec 31, 2018
Net Income
-33.37-30.6-10.24-17.91-15.28-25.8
Depreciation & Amortization
1.71.530.840.841.221.37
Share-Based Compensation
5.283.22.611.530.570.59
Other Operating Activities
4.1-0.64-12.961.431.216.15
Operating Cash Flow
-22.29-26.51-19.74-14.12-12.29-17.69
Capital Expenditures
-1.88-6.83-0.6-0.06-0.2-0.33
Acquisitions
-1.56-3.32-4.53-7.35-2.7-1.85
Investing Cash Flow
-3.44-10.15-5.12-7.41-2.9-2.18
Share Issuance / Repurchase
23.0219.6651.3936.3400
Debt Issued / Paid
-1200-0.0515-3
Other Financing Activities
-0.91-0.83-1.9-3.13-16
Financing Cash Flow
10.1118.8349.533.161513
Exchange Rate Effect
-0.08-0.09-0.210.18-0-0.04
Net Cash Flow
-15.7-17.9124.4411.82-0.19-6.9
Free Cash Flow
-24.16-33.33-20.33-14.17-12.49-18.02
Free Cash Flow Margin
-128.84%-201.89%-84.54%-124.64%-104.68%-1326.73%
Free Cash Flow Per Share
-0.39-0.59-0.44-0.45-0.44-4.27
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).